Browse studies, page 1262

Page 1262 of 1,286, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico Clinical Infectious Diseases, 2003
• A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin Antimicrobial Agents and Chemotherapy, 2000
• Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection Alimentary Pharmacology & Therapeutics, 2000
• Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis American Journal of Ophthalmology, 2004
• Comparative Pharmacokinetics of Ciprofloxacin, Gatifloxacin, Grepafloxacin, Levofloxacin, Trovafloxacin, and Moxifloxacin after Single Oral Administration in Healthy Volunteers Antimicrobial Agents and Chemotherapy, 2000
• Activity of levofloxacin and ciprofloxacin against urinary pathogens Journal of Antimicrobial Chemotherapy, 2001
• Levofloxacin efficacy in the treatment of community-acquired legionellosis CHEST Journal, 2004
• Primary Levofloxacin Resistance and gyrA/B Mutations Among Helicobacter pylori in Japan Helicobacter, 2006
• Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong CHEST Journal, 2003
• Identification of influx transporter for the quinolone antibacterial agent levofloxacin Molecular Pharmaceutics, 2006
• Levofloxacin and trovafloxacin inhibition of experimental fracture-healing Clinical Orthopaedics and Related Research, 2003
• Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery Journal of drug targeting, 2010
• Efficacies of Hybrid, High-dose Dual and Bismuth Quadruple Therapies for the First-line Anti-H Pylori Treatment and Tetracycline-levofloxacin Quadruple Therapy for the Second-line Anti-H Pylori Treatment - a Multicentre Randomized Trial ClinicalTrials.gov · COMPLETED, 2021
• Visiting Staff, Division of Gastroenterology and Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan ClinicalTrials.gov · COMPLETED, 2020
• Six- Versus Twelve-Week Therapy for Non-Surgically-Treated Diabetic Foot Osteomyelitis: A Multicenter Open-Label Controlled Randomized Study ClinicalTrials.gov · COMPLETED, 2012
• Otological Safety Profile of 100% Manuka Honey Application in Tympanoplasty: A Double-blinded Randomized Controlled Trial ClinicalTrials.gov · COMPLETED, 2022
• Tailored Antibiotic Susceptibility-guided Therapy Via Gastric Juice PCR for First-line H Pylori Eradication, a Prospective Randomized Controlled Trial ClinicalTrials.gov · COMPLETED, 2019
• A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Levofloxacin for the Treatment of Acute Bacterial Maxillary Sinusitis in Adults Undergoing Diagnostic Sinus Aspiration ClinicalTrials.gov · COMPLETED, 2004
• Comparison of the Effect Between Levofloxacin and Moxifloxacin on the Culture Conversion After 3 Months Treatment Among MDR-TB Patients; Prospective Multicenter Randomized Open Label Phase III Trial ClinicalTrials.gov · TERMINATED, 2012
• Multi-center, Randomized, Open-label Trial to Evaluate the Efficacy of Oral Fosfomycin Versus Oral Levofloxacin Strategies in Complicated Urinary Tract Infections (FOCUS) ClinicalTrials.gov · TERMINATED, 2019
• Multicenter, Double-Blind Randomized Study to Compare the Safety and Efficacy of Levofloxacin 750 mg Once Daily for Five Days vs. Levofloxacin 500 mg Once Daily for 10 Days in the Treatment of Mild to Severe Community-Acquired Pneumonia in Adults ClinicalTrials.gov · COMPLETED, 2002
• The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial ClinicalTrials.gov · COMPLETED, 2021
• A Multicenter, Randomized Study to Compare the Safety and Efficacy of Oral Levofloxacin With Amoxicillin/Clavulanate Potassium in the Treatment of Acute Sinusitis in Adults ClinicalTrials.gov · COMPLETED, 1994
• Phase II Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-angiogenic Approach ClinicalTrials.gov · TERMINATED, 2014
• Therapeutic Drug Monitoring and Pharmacokinetic Compartmental Analysis of Sulpiride ClinicalTrials.gov · COMPLETED, 2013
• VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia ClinicalTrials.gov · COMPLETED, 2020
• Short-Term Use of Antibiotics and Adherence Level: A Randomized Controlled Clinical Trial ClinicalTrials.gov · COMPLETED, 2021
• A Multicenter, Randomized, Open-Label, Comparative Study to Compare the Efficacy and Safety of Levofloxacin and Standard of Care Therapy in the Treatment of Children With Community-Acquired Pneumonia in the Hospitalized or Outpatient Setting ClinicalTrials.gov · COMPLETED, 2004
• Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery ClinicalTrials.gov · TERMINATED, 2023
• Dosing Strategy of Intravitreal Ranibizumab for Myopia Choroidal Neovascularization: a Single Center Randomized Prospective Study ClinicalTrials.gov · COMPLETED, 2018
• An Open-Label, Multicenter, Multinational, Centrally Randomized, Two-Arm Parallel-Group Study to Demonstrate the Non-Inferiority in Clinical Efficacy of Levofloxacin 750mg od in Comparison With Piperacillin/Tazobactam 4g/500mg Every 8 Hours in the Treatment of Mild to Moderate Hospital-Acquired Pneumonia Adult Patients in Both General Wards and ICU (Intensive Care Unit) ClinicalTrials.gov · COMPLETED, 2007
• Phase 4 Study on Effectiveness of Topical 0.5% Levofloxacin on Reduction of Preoperative Conjunctival Flora in Patients Scheduled for Intraocular Surgery ClinicalTrials.gov · COMPLETED, 2005
• A Randomized, Double-Blind, Comparative, Multi-Center Study of the Safety and Efficacy of TG-873870(Nemonoxacin) Versus Levofloxacin in Adult Patients With Community-Acquired Pneumonia (CAP) ClinicalTrials.gov · COMPLETED, 2007
• Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection ClinicalTrials.gov · TERMINATED, 2014
• A Phase 3, Multi-Center, Multinational, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of MP-376 (Levofloxacin Inhalation Solution; Aeroquin™) In Stable Cystic Fibrosis Patients ClinicalTrials.gov · COMPLETED, 2012
• Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (Relais Oral Dans le Traitement Des Endocardites à Staphylocoques Multi-sensibles) ClinicalTrials.gov · COMPLETED, 2024
• Comparison of Early Changes in Ocular Surface and Inflammatory Mediators Between Lenticule Extraction and Small-Incision Lenticule Extraction ClinicalTrials.gov · COMPLETED, 2014
• Phase 1b, Randomized, Single-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MP-376 Inhalation Solution Administered for 5 Days to Chronic Bronchitis Patients ClinicalTrials.gov · COMPLETED, 2008
• A National, Multicentric, Randomised, Controlled Trial. Applications of a Critical Pathway Using Levofloxacin for the Management of Patients With Abnormal PSA. ClinicalTrials.gov · COMPLETED, 2007
• A Randomized Controlled Study to Explore the Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patients With Tracheostomy ClinicalTrials.gov · TERMINATED, 2023
• Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus (Relais Oral Dans le Traitement Des Endocardites à Streptocoques Multi-sensibles) ClinicalTrials.gov · COMPLETED, 2023
• A Study of Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia ClinicalTrials.gov · COMPLETED, 2004
• Phase IV Study Comparing the Duration of Sequential Therapy ClinicalTrials.gov · COMPLETED, 2012
• Development of an Adjustment Assistance Tool Dosage of Fluoroquinolones in a Population Pharmacokinetic Model ClinicalTrials.gov · COMPLETED, 2016
• Prospective, Multinational, Multicenter, Non-Comparative, Open Study With a 6 Months Follow-up Period to Demonstrate the Efficacy and Safety of Oral Levofloxacin 500 mg Once Daily in the Treatment of Chronic Bacterial Prostatitis (CBP) ClinicalTrials.gov · COMPLETED
• A Pilot Study of Ceftolozane-Tazobactam in Conjunction With Rapid Molecular Diagnosis for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation ClinicalTrials.gov · TERMINATED, 2025
• A National, Multicenter, Non-comparative Study Evaluating the Efficacy of the Combination of Levofloxacin (500 mg) and Rifampicin (600 or 900 mg Depending on Weight) Administered Once Daily by Oral Route, as Replacement of Empirical Antibiotic Therapy Given Intravenously With a Total Duration of 6 Weeks of the Antibiotic Therapy, in the Treatment of OsteoArticular Prosthetic Infections (OAPI), With a Two-stage Revision of the Prosthesis ClinicalTrials.gov · TERMINATED, 2010
• A Monocentric, Open-label, Efficacy and Safety Evaluation Study of the Triple Therapy of 500 mg Levofloxacin, 1000 mg Amoxicillin and 30 mg Lansoprazole on Helicobacter Pylori Eradication in 60 Patients Infected With H. Pylori ClinicalTrials.gov · COMPLETED, 2011
• Efficiency of Antibacterial Prophylaxis (Levofloxacin) in Azacitidine Treated Patients ClinicalTrials.gov · COMPLETED, 2024
• Levofloxacin Pharmacokinetics in the Severely Obese ClinicalTrials.gov · COMPLETED, 2008
• Efficacy of Potassium Competitive Acid Blockers (P-CABs) Versus Proton Pump Inhibitors (PPIs) in the First and the Second Lines Eradication Regimens for H. Pylori in Egyptian Patients ClinicalTrials.gov · COMPLETED, 2023
• Efficacy of Tailored for Helicobacter Pylori Rescue Treatment Based on Antimicrobial-susceptibility Testing ClinicalTrials.gov · COMPLETED, 2018
• Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active Comparators ClinicalTrials.gov · COMPLETED
• Penetrance of Third Generation Fluoroquinolones in Eyes With Functioning Filtering Blebs ClinicalTrials.gov · COMPLETED, 2006
• Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials ClinicalTrials.gov · COMPLETED, 2013
• A Pilot, Multicenter, Open Label, Non Comparative Study of the Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media Twice Daily for Seven Days in Children With Tympanostomy Tubes ClinicalTrials.gov · COMPLETED, 2003
• The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection ClinicalTrials.gov · COMPLETED, 2012
• A Two-part, Double-blind, Placebo-controlled, Phase I Study of the Safety, Tolerability and Pharmacokinetics of SPR994 Following Single and Multiple Ascending Doses of SPR994 Administered Orally in Healthy Volunteers ClinicalTrials.gov · COMPLETED, 2018
• Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin Drug Delivery, 2016
• Repositioning of antibiotic levofloxacin as a mitochondrial biogenesis inhibitor to target breast cancer Biochemical and Biophysical Research Communications - BBRC, 2016
• Fluoroquinolone‐Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk? Pharmacotherapy, 2016
• Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies PLoS ONE, 2016
• Determination of levofloxacin in human serum using liquid chromatography tandem mass spectrometry 2018
• Preparation and Characterization of Levofloxacin-Loaded Nanofibers as Potential Wound Dressings Acta Marisiensis. Seria Medica, 2017
• Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis? Journal of Antimicrobial Chemotherapy, 2017
• A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017
• Levofloxacin-Loaded Nanoparticles Decrease Emergence of Fluoroquinolone Resistance in Escherichia coli Microbial Drug Resistance, 2018
• Application of Deep Eutectic Solvents in Hybrid Molecularly Imprinted Polymers and Mesoporous Siliceous Material for Solid-Phase Extraction of Levofloxacin from Green Bean Extract Analytical Sciences, 2017
• Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis Clinical Microbiology and Infection, 2017
• Levofloxacin-loaded bone cement delivery system: Highly effective against intracellular bacteria and Staphylococcus aureus biofilms International journal of pharmaceutics, 2017
• Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis Antimicrobial Agents and Chemotherapy, 2017
• Levofloxacin loaded mesoporous silica microspheres/nano-hydroxyapatite/polyurethane composite scaffold for the treatment of chronic osteomyelitis with bone defects Scientific Reports, 2017
• The depressed central carbon and energy metabolisms is associated to the acquisition of levofloxacin resistance in Vibrio alginolyticus Journal of Proteomics, 2018
• Pharmacokinetics, Safety, and Dosing of Novel Pediatric Levofloxacin Dispersible Tablets in Children with Multidrug-Resistant Tuberculosis Exposure Antimicrobial Agents and Chemotherapy, 2019
• One-step polymerization of hydrophilic ionic liquid imprinted polymer in water for selective separation and detection of levofloxacin from environmental matrices Journal of Separation Science, 2019
• Microextraction by Packed Molecularly Imprinted Polymer Combined Ultra-High-Performance Liquid Chromatography for the Determination of Levofloxacin in Human Plasma Journal of chemistry, 2019
• Simultaneous determination of levofloxacin and ciprofloxacin in human urine by ionic-liquid-based, dual-template molecularly imprinted coated graphene oxide monolithic solid-phase extraction Journal of Separation Science, 2019
• In vitro activity of delafloxacin against enterococcal isolates from male urinary tract infections and genetic determinants of resistance Microbiology spectrum, 2026
• Trace-level quantification of levofloxacin NDSRIs using LC-TQ-MS/MS: a multi-metric sustainability and integrated toxicological-analytical framework BMC chemistry, 2026
• Antimicrobial Resistance Profile of Helicobacter pylori in Shenzhen, China: A Retrospective Study From 2021 to 2024 Helicobacter, 2026
• LC-MS/MS method for simultaneous quantification of antibiotics in dialysis effluent and human serum for routine therapeutic drug monitoring Scandinavian journal of clinical and laboratory investigation, 2026
• Molecularly Imprinted Polymers Based on Cyclodextrin Derivatives and Chitosan for Selective Extraction of Drugs and Dyes International journal of molecular sciences, 2026
• Yersinia pseudotuberculosis employs a multifaceted strategy to survive antimicrobials 2026
• Establishment of a human osteocyte model to reveal mechanisms of chronic Staphylococcus epidermidis bone and joint infections Bone & joint research, 2026
• Molecular epidemiology of rifampicin resistant Mycobacterium tuberculosis in Vietnam 2026
• Evaluation of Posttreatment Eradication Testing Following Helicobacter pylori Therapy The Permanente journal, 2026
• Strategies to overcome intrinsic resistance in Stenotrophomonas maltophilia: In vitro activity of aztreonam/avibactam, cefiderocol, and cefepime–zidebactam 2026
• Molecular characterisation and mutational analysis of antimicrobial resistance genes in Helicobacter pylori isolates in Erbil, Iraq Mutation research, 2026
• Proteomic remodeling of outer membrane vesicles in antibiotic-resistant Helicobacter pylori reveals adaptive stress responses Frontiers in microbiology, 2026
• Challenges in establishing epidemiological cut-off values for the Burkholderia cepacia complex 2026
• Real-world safety signals of fluoroquinolone-associated peripheral neuropathy: Analysis of US and Canadian databases combined with mechanistic exploration International journal of antimicrobial agents, 2026
• Stimuli-Responsive Biopolymer Carboxymethyl Tamarind-Based Hydrogel Composite Impregnated With IONPs for Sustained Administration of Levofloxacin Chemistry, an Asian journal, 2026
• Crystal-phase-dependent interfacial lattice matching in BiOBr/Bi2O3 S-scheme heterojunctions for efficient charge separation and levofloxacin detoxification Journal of colloid and interface science, 2026
• Comparative efficacy of second- and third-generation fluoroquinolone antibiotics against systemic Escherichia coli infection in broiler chickens in Qalyubia Governorate, Egypt Scientific reports, 2026
• In vivo Activity of Combination of N-acetyl Cysteine and Levofloxacin against Colonization and Catheter-Associated Infection Current microbiology, 2026
• Longitudinal Antimicrobial Susceptibility Shifts in Environmental Legionella pneumophila from a Drinking Water Distribution System Pathogens (Basel, Switzerland), 2026
• Spectrophotometric determination of levofloxacin using bromophenol blue: insight into the structure of the formed supramolecular complex RSC advances, 2026
• High In Vitro Activity of the Novel Pleuromutilin Antibiotic, Lefamulin, on Clinical Helicobacter pylori Isolates Antibiotics (Basel, Switzerland), 2026
• Effects of levofloxacin combined with dexamethasone ear drops on suppurative otitis media and analysis of influencing factors American journal of translational research, 2026
• Epidemiology and Antimicrobial Resistance of Salmonella Isolates from Children in China (2017–2024) from a Multicenter ISPED Program 2026